Related Experiment Video
Updated: Aug 21, 2025
09:08
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
3.8K
SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells
Yang Liu1,2,3, Jian Rao4, Yingjie Mi1,2
1State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Frontiers in Immunology
|November 17, 2022
Summary
RNA interference (RNAi) may combat SARS-CoV-2 in interferon-deficient cells. Host microRNAs are dysregulated, and virus-derived small RNAs show specific patterns, suggesting RNAi
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic causes significant global fatalities.
- RNA interference (RNAi) antiviral roles are established in other organisms but debated in mammals due to interferon (IFN) suppression.
- Understanding RNAi's role in mammalian SARS-CoV-2 resistance is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of RNAi in mammalian cells during early SARS-CoV-2 infection.
- To profile host small RNAs and SARS-CoV-2 virus-derived small RNAs (vsRNAs) in IFN-deficient cells.
- To explore potential alternative antiviral strategies for IFN-deficient patients.
Main Methods:
- Analysis of host small RNAs and SARS-CoV-2 vsRNAs in Vero cells (IFN-deficient) during early infection.
- Profiling of microRNA (miRNA) dysregulation in response to SARS-CoV-2.
- Characterization of vsRNA size, strand specificity, and Dicer-slicing patterns.
- Comparison with vsRNA profiles from Sindbis and Zika virus infections in IFN-deficient cells.
Main Results:
- SARS-CoV-2 infection dysregulated host miRNAs, downregulating antiviral miRNAs and upregulating proviral miRNAs.
- vsRNAs peaked at 22 nt on the negative strand of SARS-CoV-2 and exhibited Dicer-spliced patterns on both strands.
- Similar vsRNA characteristics were observed in IFN-deficient cells infected with other viruses.
Conclusions:
- The RNAi pathway may be deployed by host cells to combat SARS-CoV-2 infection, particularly in IFN-deficient environments.
- Dysregulation of host miRNAs suggests a complex interplay between the virus and cellular regulatory mechanisms.
- Findings support the development of alternative antiviral strategies targeting RNAi for patients with compromised IFN signaling.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
01:29Viruses with RNA Genomes
86
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
86
02:30siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
01:10Retrovirus Life Cycles
46.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
02:28Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
01:23RNA Interference
26.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K